• <xmp id="1ykh9"><source id="1ykh9"><mark id="1ykh9"></mark></source></xmp>
      <b id="1ykh9"><small id="1ykh9"></small></b>
    1. <b id="1ykh9"></b>

      1. <button id="1ykh9"></button>
        <video id="1ykh9"></video>
      2. west china medical publishers
        Author
        • Title
        • Author
        • Keyword
        • Abstract
        Advance search
        Advance search

        Search

        find Author "朱洪生" 18 results
        • 自身成體干細胞移植治療心肌梗死

          心血管疾病,尤其是心肌梗死已成為人類死亡的主要疾病.自身成體干細胞移植為心肌梗死的治療帶來了新的希望.目前可供移植的種子細胞包括骨骼肌衛星細胞,骨髓干細胞,內皮祖細胞,自體移植避免了免疫排斥和倫理道德問題.近期實驗表明移植的干細胞能在心肌疤痕中存活,增強心功能.當前需要進一步研究干細胞移植后與心肌微環境的聯系,理想的移植細胞數目和移植技術以及對整個心功能可能產生的影響.

          Release date:2016-08-30 06:32 Export PDF Favorites Scan
        • P-選凝素與心肌缺血-再灌注損傷

          研究心肌缺血-再灌注損傷中P-選凝素(P-selectin)的重要作用.P-selectin是一種糖蛋白黏附因子, 存在于內皮細胞和血小板,并介導血小板、內皮細胞和多形核白細胞(PMNs)等之間的相互作用,且與一氧化氮有著密切的關系,形成了許多復雜的炎癥病理過程,在心肌缺血-再灌注損傷中起到了關鍵的作用.特別是P-selectin與晚期再灌注損傷、血小板及心肌損傷中治療作用、最新的P-selectin基因缺陷小鼠和糖尿病小鼠等的心肌缺血-再灌注損傷中表現的深入研究,使其在缺血-再灌注損傷中的重要性和復雜性顯得更加突出.

          Release date:2016-08-30 06:32 Export PDF Favorites Scan
        • 冠狀動脈旁路移植術患者術后早期運動耐量改善的影響因素

          目的 探討冠狀動脈旁路移植術(CABG)患者術后早期運動耐量改善的影響因素,以提高手術療效.方法隨機選擇30例行CABG患者,術前和術后1~3個月進行平板運動試驗(TET),以手術前后運動功量的差值為應變量,各項臨床指標與手術情況為自變量,進行Logistic多元回歸分析. 結果 無手術死亡.術后運動功量等運動耐量指標及心肌缺血指標有明顯改善(Plt;0.001),術前左心功能、心肌梗死史、心絞痛、高血壓和乳內動脈(IMA)移植是影響手術療效的主要因素. 結論 CABG能顯著提高運動耐量,改善心肌缺血,了解并重視這些影響因素將有助于更好地選擇手術病例,預測手術療效.

          Release date:2016-08-30 06:32 Export PDF Favorites Scan
        • 血管緊張素轉換酶抑制劑對心肌再灌注損傷的作用

          心肌再灌注損傷可表現為再灌注性心律失常、心肌頓抑和心肌壞死.研究表明心臟局部的腎素血管緊張素系統和冠狀動脈內皮細胞功能失常在心肌再灌注損傷中起重要作用.血管緊張素轉換酶抑制劑能抑制轉換酶活性,減少血管緊張素Ⅱ的形成,并能作用于激肽酶Ⅱ,抑制緩激肽的降解,后者可促進前列環素和一氧化氮(NO)的產生.近年來血管緊張素轉換酶抑制劑被用于防護心肌再灌注損傷,在防護再灌注性心律失常、心肌頓抑和心肌壞死等方面顯示了較好的治療效果.

          Release date:2016-08-30 06:35 Export PDF Favorites Scan
        • MicroRNA-129 Promotes Cardiomyogenesis in Bone Marrow Mesenchymal Stem Cells

          Objective To explore the induction of cardiomyogenesis of microRNA-129 (mir-129) in rat bone marrowmesenchymal stem cells (BM-MSCs) and its mechanism. Methods BM-MSCs were isolated from Sprague-Dawley rats and cultured in vitro. Overexpression of mir-129 or both mir-129 and glycogen synthase kinase-3β (GSK-3β) in BM-MSCs was produced with a lentiviral vector system. All the BM-MSCs were divided into four groups: control group (MSCs),Lentiviral vectors+MSCs group (Lv-MSCs),mir-129 transfection group (mir-129-MSCs),and mir-129+GSK-3βdouble transfection group (mir-129+GSK-3β-MSCs). Five-Azacytidine (5-Aza) (10 μmol/L) was used to induce BM-MSCsdifferentiation into cardiomyocytes. On the 1st,5 th,10 th,15 th and 20 th day after induction,realtime-PCR was performedto detect mRNA levels of GATA-4,Nkx2.5 and MEF-2C. On the 10 th,15 th and 20 th day after induction,Western blottingwas performed to examine expression levels of cTnI,Desmin,GSK-3β,phosphorylated β-catenin and dephosphorylated β-catenin. Results Compared with the control group,at respective time points,mRNA levels of cardiomyogenic genes and expression levels of cardiomyocyte-related proteins of mir-129 transfection group were significantly elevated,theexpression level of GSK-3β was significantly decreased,and the ratio of dephosphorylated/phosphorylated β-catenin was significantly elevated. When both mir-129 and GSK-3β were overexpressed in BM-MSCs,mRNA levels of cardiomyogenicgenes and expression levels of cardiomyocyte-related proteins were significantly lower than those of mir-129 transfection group,and the ratio of dephosphorylated/phosphorylated β-catenin was significantly decreased. Conclusion Overexpression of mir-129 can promote cardiomyogenesis of rat BM-MSCs possibly via inhibiting GSK-3β production and thus decreasing the inhibition of phosphorylation of β-catenin which then enters the nucleus and activates downstream signaling pathways that regulate cardiomyogenic differentiation of BM-MSCs.

          Release date:2016-08-30 05:47 Export PDF Favorites Scan
        • 梗死心肌骨骼肌衛星細胞移植后心肌細胞結蛋白變化

          目的 觀察骨骼肌衛星細胞梗死心肌移植后心肌細胞結蛋白的變化。方法 自犬臀部取骨骼肌體外提取、培養、擴增骨骼肌衛星細胞,4’,6-二脒基-2-苯吲哚(DAPI)熒光標記,經結扎的左冠狀動脈前降支遠端灌注移植入自體急性心肌梗死區域,2周、4周和8周后將犬處死,取病理標本行免疫組織化學檢測心肌細胞結蛋白表達、組織切片染色觀察組織結構。結果 在梗死區部位觀察到帶熒光的細胞核及纖維,部分已分化成橫紋肌并以閏盤相連。正常區域心肌細胞結蛋白排列位于心肌細胞Z線處,可見清晰顯示的肌小節;梗死區心肌細胞結蛋白表達明顯高于正常區域心肌細胞,但排列紊亂,整個心肌細胞均見陽性表達的結蛋白,未見肌小節;4周、8周時治療部分梗死心肌細胞已恢復排列并重見肌小節,但梗死區心肌細胞結蛋白表達仍明顯高于正常區域心肌細胞(P〈0.01)。結論 骨賂肌衛星細胞梗死心肌移植后對梗死心肌的組織結構起到了保護作用,使心肌細胞結蛋白分布恢復正常。

          Release date:2016-08-30 06:35 Export PDF Favorites Scan
        • 胸腺瘤合并重癥肌無力及單純紅細胞再生障礙性貧血二例

          Release date:2016-08-30 06:23 Export PDF Favorites Scan
        • 雙瓣膜置換患者圍術期心排血量與呼出氣二氧化碳的關系

          目的 探討雙瓣膜置換術患者圍術期心排血量監測,提高手術安全性和預測患者預后,及時調整治療方案.方法 根據Fick原理將呼出氣二氧化碳(ETCO2)監測用于估計患者圍術期心排血量(CO),并與有創性溫度稀釋法進行比較.將1991年10月以來隨機選擇20例雙瓣膜置換患者分為兩組,對照組:使用常規心肌保護液;用藥組:常規心肌保護液中加入山莨菪堿,30mg/L.常規體外循環,冠狀竇逆行灌注,分別于麻醉前、轉流前、轉流結束、手術結束、術后2小時、4小時、8小時、12小時和24小時測定心臟指數(CI)、左心室收縮做功指數(LVSWI)、右心室收縮做功指數(RVSWI)、肺血管阻力(PVR)、全身血管阻力(SVR)、ETCO2、動脈血二氧化碳分壓(PaCO2).結果 對照組恢復心臟灌注后CO的增加與ETCO2變化無相關關系,用藥組CO增加較對照組顯著,且與ETCO2密切相關,CO的變化與ETCO2在各時點的變化呈正相關(P<0.05);同時對照組在心臟復跳后PaCO2持續增加與術前及同時間用藥組相比有差異(P<0.05).結論 山莨菪堿可改善肺循環,減少分流,可使ETCO2正確地反映CO變化,是一種既無創,又方便、經濟并能連續進行CO監測的方法.

          Release date:2016-08-30 06:35 Export PDF Favorites Scan
        • The influence of autologous bone mesenchymal stem cells on myocardial structure and cardiac function after being implantated into acute infarcted myocardium

          Objective To study the influence of autologous bone mesenchymal stem cells (BMSCs) on myocardial structure and cardiac function after being implantated into acute infarcted myocardial site. Methods Bone marrow was aspirated from the posterosuperior iliac spine of Guizhou Xiang swine. After being isolated, cultured and co cultured with 5 azacytidine, either autologous BMSCs (total cells 2×10 6, experimental group, n =12), or a comparable volume of culture medium (control group, n =12), was injected into the left anterior descending(LAD) branch of coronary artery just distal to the ligation site of the LAD. The same volume of BMSCs or culture medium was injected into several spots in the infarcted myocardium. Echocardiographic measurements were performed three or six weeks after implantation to assess the myocardial structure and cardiac function. Results Left ventricular function, including eject fraction(EF), fractional shortening and wall thickening, were higher in experimental group when compared with control group. The thickness of the ventricular wall and septum was also found increased while the left ventricular chamber size was smaller in experimental group. Conclusion Implantation of BMSCs into the infarcted myocardium is believed to attenuate the remodeling process, inhibit the extent of wall thinning and dilatation of the ventricular chamber. BMSCs implantation may also improve the contractile ability of the myocardium and cardiac function.

          Release date:2016-08-30 06:27 Export PDF Favorites Scan
        • The Short and Medium Term Effect on Myocardial Contractile Force after Implantation of Autologous Endothelial Progenitor Cells

          Objective To study the short and medium term effect of myocardial contractile force by implantation of endothelial progenitor cells (EPCs) in the myocardial infarction model. Methods Hundred and twenty SD rats were equally and randomly divided into experimental group and control group (60 rats in each group). Acute myocardial infarction model was created by ligation of LAD. Autologous EPCs were purified from peripheral blood then implanted into the acute myocardial infarct site via topical injection. IMDM were used in control group. Specimens and muscle strip were harvested at 3, 6 weeks, 6, 8 and 12 months after EPCs implantation for contractile force study and to detect the expression of vascular endothelial growth factor(VEGF), basic fibroblast growth factor (bFGF) and Ⅷ factor by immunohistology and video image digital analysis system. Results The expression of VEGF, bFGF and the microvessel counts in experimental group were much higher than those of control group(P〈 0.01) at 3, 6 weeks and 6 months after transplantation. The contractile force in experimental group was better than that in control group(P〈0.01) at the same time. But from 8 months after implantation, the contractile force and so on were not up in the experimental group. Conclusion EPCs, after being implanted into infarct myocardium, shows the ability of improvement of the contractile performance in infarcted myocardium by means of angiogenesis and vasculogenesis and the medium term results are persistent.

          Release date:2016-08-30 06:23 Export PDF Favorites Scan
        2 pages Previous 1 2 Next

        Format

        Content

      3. <xmp id="1ykh9"><source id="1ykh9"><mark id="1ykh9"></mark></source></xmp>
          <b id="1ykh9"><small id="1ykh9"></small></b>
        1. <b id="1ykh9"></b>

          1. <button id="1ykh9"></button>
            <video id="1ykh9"></video>
          2. 射丝袜